 |
  
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
U.S. News Pennsylvania Public Welfare Expands Drug Benefits for HIV PatientsNovember 17, 2003 Pennsylvania Public Welfare Secretary Estelle Richman recently announced the addition of Emtriva (emtricitabine) and Reyataz (atazanavir sulfate) for the treatment of HIV/AIDS to the Special Pharmaceutical Benefits Program (SPBP). The program now offers 72 different types of drugs and treatments for its 5,000 HIV/AIDS patients. The pills are taken once daily, reducing the pill burden often associated with combination therapy. To be eligible for SPBP, non-institutionalized Pennsylvania residents must have a medical need and an individual gross income of less than $30,000, with an additional allowance of $2,480 for each additional family member. AIDS Weekly 11.10.03  This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. |
 |
Email
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
